We are live on
!
Find out more
RG
Renaissance Group Portfolio holdings
AUM
$2.46B
Turnover
16.47%
1-Year Est. Return
32.78%
This Fund
S&P 500
This Quarter
Est. Return
+7.85%
1 Year Est. Return
+32.78%
3 Year Est. Return
+114.54%
5 Year Est. Return
+163.28%
10 Year Est. Return
+573.7%
AUM
$2.31B
AUM Growth
+$133M
(+6.1%)
Cap. Flow
-$2.47M
Cap. Flow
% of AUM
-0.11%
Top 10 Holdings %
Top 10 Hldgs %
16.06%
Holding
283
New
13
Increased
140
Reduced
117
Closed
12
Avg Time Held
2.8
years
Top 10 Avg Time Held
0.6
years
Top 20 Avg Time Held
0.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$29.6M |
| 2 |
Marriott International
MAR
|
+$29.6M |
| 3 |
Keysight
KEYS
|
+$29M |
| 4 |
Cigna
CI
|
+$28.8M |
| 5 |
HITACHI LTD ADR (10COM)NEW
HIT
|
+$6.79M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$28.7M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$26.8M |
| 3 |
Ulta Beauty
ULTA
|
+$26.3M |
| 4 |
Raymond James Financial
RJF
|
+$21.9M |
| 5 |
Meta Platforms (Facebook)
META
|
+$11.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.54% |
| 2 | Healthcare | 17.17% |
| 3 | Industrials | 9.85% |
| 4 | Consumer Discretionary | 8% |
| 5 | Miscellaneous | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
MKS Inc
MKSI
$14.5B
| $672K | 0.03% |
6,212
-711
| -10% | -$65.1K |
2021 Q2
8 quarters
|
|
177
Sysco
SYY
$40.4B
| $665K | 0.03% |
8,960
-879
| -9% | -$65K |
2019 Q3
15 quarters
|
|
178
Crown Holdings
CCK
$12.4B
| $652K | 0.03% |
7,500
-684
| -8% | -$56.3K |
2017 Q2
24 quarters
|
|
179
Capital One
COF
$124B
| $618K | 0.03% |
5,646
-485
| -8% | -$48.6K |
2014 Q3
35 quarters
|
|
180
Donaldson
DCI
$10.2B
| $592K | 0.03% |
9,473
-1,084
| -10% | -$67.8K |
2021 Q1
9 quarters
|
|
181
Home Depot
HD
$309B
| $563K | 0.02% |
1,813
-2,466
| -58% | -$728K |
2013 Q2
40 quarters
|
|
182
AbbVie
ABBV
$504B
| $560K | 0.02% |
4,153
-463
| -10% | -$67.9K |
2018 Q1
21 quarters
|
|
|
HZNP
183
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $529K | 0.02% |
5,143
-253,772
| -98% | -$26.8M |
2020 Q1
13 quarters
|
|
184
Dominion Energy
D
$55.9B
| $510K | 0.02% |
9,843
-845
| -8% | -$45.9K |
2022 Q2
4 quarters
|
|
|
185
Ulta Beauty
ULTA
$25.4B
| $508K | 0.02% |
1,079
-53,735
| -98% | -$26.3M |
2021 Q4
6 quarters
|
|
186
Microchip Technology
MCHP
$40.1B
| $365K | 0.02% |
4,078
+315
| +8% | +$24.9K |
2022 Q1
5 quarters
|
|
187
Linde
LIN
$230B
| $304K | 0.01% |
798
+70
| +10% | +$25.6K |
2022 Q4
2 quarters
|
|
188
Ameriprise Financial
AMP
$44.2B
| $302K | 0.01% |
909
+84
| +10% | +$25.8K |
2020 Q2
12 quarters
|
|
189
Synopsys
SNPS
$87.1B
| $302K | 0.01% |
693
| – | – |
2022 Q2
4 quarters
|
|
190
Parker-Hannifin
PH
$121B
| $289K | 0.01% |
742
-108
| -13% | -$36.5K |
2020 Q3
11 quarters
|
|
191
DELISTED
Discover Financial Services
DFS
| $289K | 0.01% |
2,475
+257
| +12% | +$26.9K |
2020 Q4
10 quarters
|
|
192
Aflac
AFL
$60.1B
| $287K | 0.01% |
4,116
+384
| +10% | +$25.7K |
2020 Q4
10 quarters
|
|
|
193
Texas Instruments
TXN
$252B
| $283K | 0.01% |
1,571
-166,656
| -99% | -$28.7M |
2014 Q2
36 quarters
|
|
194
CenterPoint Energy
CNP
$26.7B
| $282K | 0.01% |
9,685
+820
| +9% | +$24.2K |
2020 Q4
10 quarters
|
|
195
Marathon Petroleum
MPC
$134B
| $279K | 0.01% |
2,393
+192
| +9% | +$22.3K |
2020 Q4
10 quarters
|
|
196
Simon Property Group
SPG
$66.5B
| $279K | 0.01% |
2,413
+227
| +10% | +$24.7K |
2020 Q3
11 quarters
|
|
197
Gilead Sciences
GILD
$194B
| $276K | 0.01% |
3,575
+297
| +9% | +$23.7K |
2022 Q2
4 quarters
|
|
198
Masco
MAS
$14.4B
| $273K | 0.01% |
4,759
+524
| +12% | +$27.4K |
2023 Q1
1 quarter
|
|
199
Tanger
SKT
$4.07B
| $260K | 0.01% |
11,780
-578
| -5% | -$11.6K |
2022 Q4
2 quarters
|
|
200
Travelers Companies
TRV
$81.2B
| $258K | 0.01% |
1,487
+146
| +11% | +$25.8K |
2020 Q4
10 quarters
|
|
Similar funds
MAMU
SGAM
PC
VCM
DIA
Renaissance Group's Q2 2023 Portfolio in Review
As of Q2 2023, Renaissance Group held 283 positions worth $2.31B, up 6.1% from $2.18B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Renaissance Group's Q2 2023 filing shows 13 new, 140 increased, 117 reduced and 12 closed positions. Its largest new stake was Lam Research: 525,840 shares worth $33.8M. The largest sale was Texas Instruments, an estimated $28.7M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 32% a quarter earlier, followed by Healthcare and Industrials.
- Renaissance Group's largest Q2 2023 buy was Lam Research: 525,840 shares worth $33.8M.
- Renaissance Group added most to Cigna in Q2 2023, an estimated $28.8M increase.
- Renaissance Group's biggest Q2 2023 reduction was Texas Instruments, cutting an estimated $28.7M.
- Renaissance Group fully exited Raymond James Financial in Q2 2023, selling an estimated $21.9M.
- Renaissance Group's ten largest holdings make up 16% of its $2.31B portfolio in Q2 2023.
- Renaissance Group opened 13 new positions and closed 12 in Q2 2023.
- Renaissance Group's portfolio value rose 6.1% quarter-over-quarter to $2.31B.
Based on Renaissance Group's 13F filing for Q2 2023, filed 10 Aug 2023.